Investors Asset Management of Georgia’s Novo Nordisk NVO Stock Holding History

Investors Asset Management of Georgia’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$273K	Buy	+5,685	New	+$244K	0.09%	169

Other funds holding NVO

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Investors Asset Management of Georgia's NVO Position: Q2 2026 in Review

Investors Asset Management of Georgia opened a new position in Novo Nordisk (NVO) in Q2 2026: 5,685 shares worth $273K. The stake represents 0.09% of the portfolio and ranks #169 among its holdings.

1,041 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Investors Asset Management of Georgia held 5,685 shares of Novo Nordisk worth $273K as of Q2 2026.
Novo Nordisk was a new Investors Asset Management of Georgia position in Q2 2026.
Novo Nordisk made up 0.09% of Investors Asset Management of Georgia's portfolio in Q2 2026, its #169 holding.
1,041 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Investors Asset Management of Georgia's 13F filing for Q2 2026, filed 22 Jul 2026.